The aim of our study was to assess the medium-term clinical outcomes of anterior cruciate ligament (ACL) reconstruction using the Ligament Advanced Reinforcement System (LARS) artificial ligament.
Introduction
Anterior cruciate ligament (ACL) injury is a primary cause of knee instability and is associated with secondary damages to the intra-and peri-articular structures of the knee, which may result in articular degeneration. [1] ACL reconstruction is a wellestablished and acknowledged surgical technique for ACL injury and is currently being applied worldwide. [2] The graft options for ACL include three main types: autograft, allograft, and synthetic graft. Compared to autograft and allograft, using a synthetic graft can effectively avoid risks of donor site morbidity and disease transmission but can cause higher rates of graft failure and late inflammation. [3, 4] Historically, in the late 1980s and early 1990s, synthetic ACL reconstruction was considered suspect, especially due to the Gortex experience with its high ratio of long-term complications, although the short-term clinical results were appealing. [5, 6] Tearing of the prosthetic ligament was the most feared and frequent complication. [7, 8] With the development of biomechanics and material science, a novel synthetic ACL graft called the Ligament Advanced Reinforcement System (LARS; Surgical Implants and Devices, Arc-sur-Tille, France) was developed. After decades of discussions and arguments, the use of LARS remains a controversial issue. In 2013, Parchi et al [9] did not record any cases of infections or knee synovitis and only one case of mechanical graft failure. In 2015, a study indicated that LARS should currently not be suggested as a potential graft for primary reconstruction of the Editor: Leonardo Roever.
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ACL based on a minimum 10-year follow-up of 18 patients. [10] An editorial commentary stated that LARS may not be perfect, but LARS clinical outcomes are surprisingly impressive. [11] The purpose of our study was to evaluate the medium-term clinical outcome of ACL reconstruction with LARS at a single institution from 2004 to 2010. It was hypothesized that using the LARS artificial ligament for ACL reconstruction was effective and safe, with a low failure rate and low incidence of complications.
Materials and methods

Patients and data collection
This work was an observational case series study and was conducted in the orthopedics department of Changhai Hospital from February 2016 to August 2016. This study was conducted under the medical Ethics Committee of Changhai Hospital Affiliated to Second Military Medical University (Permit Number: 2016-008). All participants in this study signed informed consent forms to publish the related data.
From January 2004 to January 2011, 168 patients underwent arthroscopic ACL reconstruction using the LARS artificial ligament in our hospital. ACL rupture was diagnosed based on medical history, physical examination, and MRI examination. All patients were actively engaged in daily work and sports activity before injury. All of them were informed of the benefits and risks of ACL reconstruction with the LARS artificial ligament, and informed consent was signed before the surgery.
The inclusion criteria were as follows: (1) date of surgery: 2004/1/1-2010/12/30, (2) ACL reconstruction using the LARS system, (3) chondral lesions Grade 2 (Outerbridge Classification), (4) knee osteoarthritis < Grade III (Kellgren-Lawrence Grading Scale). The exclusion criteria were as follows: (1) revision ACL reconstruction, (2) multiple ligament injuries (medial collateral ligament injury without operation excluded), (3) operation history of knee, (4) trauma history for the contralateral side of the knee. ACL failure is defined as either ACL graft re-rupture diagnosis by MRI or a pivot shift test greater than grade 2, KT-1000 side-to-side difference of >5 mm and extension >5 and flexion deficit >15°according to the contralateral side. Complications included infection, synovitis, failure of fixation, and articular stiffness.
Physical examinations including the Lachman test, Pivot-shift test, and KT-1000 arthrometer measurement (MEDmetric, San Diego, CA) were performed to evaluate knee laxity. Participants were asked to fill in two self-assessment instruments, the International Knee Documentation Committee (IKDC), and the Lysholm knee score. The Tegner score was calculated for the level of return to sport, and the reasons patients could not return to sport were collected. The range of motion (ROM) was measured during follow-ups. Demographic data were also collected, including age, gender, affected side, BMI, duration of follow-up, cause of injury, and time from injury to operation. In order to reduce the effects of patients lost to follow-up, demographic data were compared between follow-up patients and patients lost to follow-up.
Operative procedure
Routine arthroscopy was performed on all patients, and any meniscal injuries and/or cartilaginous lesions were treated before ACL reconstruction.
ACL reconstruction with LARS was undertaken following isometric surgical principles, which have been previously described. [13] The ACL stumps were routinely preserved. The intra-articular point of the tibial tunnel was positioned at the anteromedial part of the tibial footprint of the ACL from the anteromedial tibial cortex by a tibial aimer with a Kirschner wire inserted. Then, the tibial tunnel was drilled using a 7.5 mm diameter drill bit. The intra-articular femoral tunnel was placed by the transtibial technique at the 11:00-o'clock position (right)/ 1:00-o'clock position (left). The 7.5 mm diameter drill bit guided by the Kirschner wire was drilled into the femur from the anterolateral thigh into the knee joint. The LARS artificial ligament was introduced into the knee joint from the extraarticular opening of the tibial tunnel, guided by a wire. It was ensured that the full range of knee motion was achieved and there was no impingement among LARS artificial ligaments, the notch, and the PCL. Titanium interference-fit screws (Surgical Implants and Devices) were used for fixation of the LARS artificial ligament at both the tibial and femoral sides with a diameter of 8 mm on the femoral side and 9 mm on the tibial side at a knee flexion of 30° (Fig. 1 ).
Rehabilitation
Unlocked functional braces were used for 24 hours in the first 2 weeks after operation and only used during walking between 2 and 4 weeks after surgery. To strengthen the quadriceps, legraising exercises with the brace at least 200 times a day were recommended beginning as soon as possible after surgery. A ROM of 45°could be achieved within 2 weeks after the operation and 120°within 8 weeks. Walking without crutches was allowed beginning at least 4 weeks after surgery.
Statistical analysis
Continuous data with normal distribution were expressed as the mean and standard deviation, and continuous data with nonnormal distribution or noncontinuous data were expressed as the median with ranges given. For statistical analyses, the Chi-squared test was used for categorical variables, and Student's t-test was used for continuous variables with normal distribution. A P value of less than 0.05 was considered statistically significant for all analyses. The analyses were performed in SSPS for Windows Release 20.0 (Chicago, IL).
Results
Of all 168 patients, 125 satisfied the inclusion/exclusion criteria, and 34 were lost to follow-up (Fig. 2) . Hence, the follow-up rate was 72.8%. A total of 91 patients were eventually enrolled in our research, including 61 males (67.0%) and 30 females (33.0%) ( Table 1 ). The average age was 36 ± 11 years (range, 20-64 years), and the mean duration of follow-up was 92 ± 19 months (range, 66-135 months). The median duration between injury and surgery was 19 weeks (range, 1-1260). Of all patients included, 50 patients (54.9%) suffered from an ACL injury accompanied by meniscus injury. The demographic baseline between follow-ups and patients lost to follow-up showed no significant difference (P > 0.05).
At the final follow-up, the failure rate of ACL reconstruction using the LARS artificial ligament was 4.4% (4/91). One patient had limited ROM, where the flexion angle of the affected knee was 30°smaller than on the normal side, and one was diagnosed with mechanical graft failure during revision surgery (Fig. 3) . Two patients had a side-to-side difference of more than 5 mm. The complication rate was 2.2% (2/91). One patient suffered from a superficial surgical site infection and was cured by antibiotics 7 months after surgery. Screw loosening occurred in another patient due to osteoporosis with replacement by a larger screw 4 months later.
The side-to-side difference in knee laxity measured by a KT-1000 arthrometer was 1.4 ± 1.5 mm (range, 0-4 mm), which was significantly decreased compared with the preoperative value of 5.1 ± 1.3 (range, 4-10 mm) (P< 0.0001). Postoperatively, only 2 patients (2.2%) had a side-to-side difference of more than 5 mm. The results of the Lachman test and pivot-shift test are given in Table 2 . Only one patient had obvious ROM limitation compared with the contralateral side.
The mean Lysholm score improved from 54.6 ± 14.3 (range, 20-90) to 85.4 ± 12.1 (range, 20-100) (P < 0.0001). According to the IKDC score standard, 63 cases were classified as grade C 
Discussion
The most importing findings of this study were the low failure rate and the low complication rate. The failure rate was 4.4% (4/ 91), including two cases of recurrent instability, one case of limitation of ROM and one artificial graft rupture. According to a review of the recent literature, the failure rate was 4.75% (23/ 484) in all studies where the mean follow-up was longer than 3 years (Table 3) . [9, 10, 12, [14] [15] [16] [17] [18] [19] There were 9 cases of graft rupture and 14 cases of recurrent instability. Among these 9 cases, 6 were due to a new trauma, and 1 case was injury in a high-level sport activity. One patient who suffered artificial graft rupture in our research was a judoka and returned to judo training. He was reinjured in daily training. Hence, the possibility of graft rupture without new injuries was comparatively low. Pan et al [12] reported similarly good clinical results after ACL reconstruction using bone-patellar tendon-bone (BPTB) autografts or LARS artificial grafts at a midterm follow-up. The rate of recurrent instability was 9.38% (3/32) for LARS and 6.67% (2/30) for BPTB autografts. Dericks reported that the failure rate was 4% in 220 cases receiving ACL reconstruction with the LARS artificial ligament after a mean follow-up of 2.5 years, which was similar to our results. [13] Since the graft was located in a nonanatomic and isometric placement, the tensional force in vivo was less, and the graft survival was higher than for an anatomically reconstructed graft.
The overall complication rate in our research was 2.2% (2/91), with one case of screw loosening and one case of infection. No synovitis occurred in our study, and synovitis appears to be a rare complication closely related to imperfect graft positioning. [20] However, when the complication of synovitis does occur, it can be very severe. Li et al [17] reported a case of rare serious knee synovitis 3 years postoperatively, possibly due to poor remodelling of the artificial ligament. Bone impingement caused by malposition of the bone tunnel has often been a primary reason for failure and complications. [21] Infection and screw loosening/pain related to screws were most frequently reported. [10, 15] Based on observation of the histological characteristics and ultrastructure of the LARS ligament in vitro, inflammation and foreign body reaction were enhanced, but the LARS ligament had good in-growth capability based on the findings of fibrous connective tissue formation. [22] Although the complication rate was not high, methods to promote the biocompatibility of the LARS artificial ligament needed further study.
The LARS artificial ligament was initially invented by JP Laboureau and made of polyethylene terephthalate (PET). It was a "scaffold" graft but has not yet been Food and Drug Administration (FDA) approved in the United States, and its use for the most part has occurred in France and Australia. LARS can be divided into two parts: the intra-articular portion and the extra-articular portion. The intra-articular portion consists of longitudinal external rotation fibers with no transverse fibres, in imitation of the ACL anatomical structure, while the extraarticular portion is woven of longitudinal and transverse fibers to avoid ligament deformation. LARS has good biomechanics in terms of resisting tension, flexion, and torsion load. [23, 24] Knee functions were evaluated by assessing the IKDC score and the Lysholm knee score. The Tegner score was tested for the ability to return to sport. Similar to previous studies, the IKDC score and the Lysholm score both increased significantly. [9, 15, 16] It indicated a good recovery of knee function. However, the Tegner score showed a significant difference between the preinjury and postoperative periods. There was no case in which the postoperative level of activity was higher than pre-injury, and only 46 cases could return to the pre-injury level of activity. Moreover, 12 cases could not return or refused to engage in sport activities. The reasons for the decrease in the Tegner score included multiple factors. After detailed inquiries, psychological factors played an important role, as most of them feared another injury. Only 5 cases could not return to sport activity due to knee dysfunction. Another reason some refused to return to sport activity was social and economic factors, as they complained of being busy with work and having limited time. Eleven patients were students before the injury and had since taken a job, so they gave up playing football or basketball for personal reasons.
Compared to previous research, the short-term results were appealing, but the long-term follow-up results were controversial. Tiefenboeck et al indicated that the LARS artificial ligament should not be suggested as a potential graft for primary ACL reconstruction based on research at a minimum follow-up of 10 years. However, this research might not accurately represent the long-term results of the LARS ligament because the sample size was small (n = 18). [10] The same problem was present in another study at a mean follow-up of 8 years (n = 29), but this study documented a good result for the LARS ligament. [9] To ensure the follow-up time as well as the sample size, patients who accepted ACL reconstruction over at least 7 years in our hospital were enrolled in our research. The results tended to support LARS ligaments for primary ACL reconstruction.
There were two limitations in our study. First, the follow-up rate was comparatively low due to changes in contact information and geographical factors. However, the demographic data between follow-ups and patients lost to follow-up showed no significant difference, which indicated good representativeness of the follow-up data. Second, no control group was evaluated because there were not enough cases of other surgical methods for long-term evaluation.
Conclusions
In this research, ACL reconstruction using the LARS artificial ligament has a good prognosis with a low failure rate and complication rate for at least 7 years. It can serve as a suitable choice for fast recovery of the anterior cruciate ligament.
